Keros Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2019 | — | -105.6% | -123.4% |
| FY2021 | — | -280.5% | -292.3% |
| FY2023 | — | -112,543.7% | -101,319.2% |
| FY2025 | — | 27.7% | 35.7% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2019 | — | -105.6% | -123.4% |
| FY2021 | — | -280.5% | -292.3% |
| FY2023 | — | -112,543.7% | -101,319.2% |
| FY2025 | — | 27.7% | 35.7% |